Sex Differences in Mortality and Receipt of Kidney Replacement Therapy Among Adults With Stage 5 Chronic Kidney Disease

Further Publications Urology

System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland

Adv Ther

Campbell-James T, Buff S, Nanchen G, Hall A, Rosemann T, Nicholson L, Priest S, Zara A, Hubbert L, Vecchio Rodriguez C, Wharton G, Pruijm M

doi: 10.1007/s12325-026-03519-1

Further Publications Urology

Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus

Adv Ther

Handelsman Y, Cheng AYY, Fadini GP, Kushner P, Bonnet F, Fioretto P, Kadowaki T, Kanumilli N, Cos X, Frese T, Ji L, Rossing P

doi: 10.1007/s12325-026-03618-z

Further Publications Urology

Chronic kidney disease

Lancet

Herrington WG, Judge PK, Grams ME, Wanner C

doi: 10.1016/S0140-6736(25)01942-7

Further Publications Urology

Advances in understanding the impact of sex on kidney health and disease

Lancet

Lees JS, Stevens KI, Kotwal SS, Bruchfeld A, Levin A

doi: 10.1016/S0140-6736(26)00654-9

Further Publications Urology

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)

Lancet

Neuen BL, Heerspink HJL, Perkovic V, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Jongs N, Smeijer JD, Brinker M, Ahlers C, Lage A, Horvat-Bröcker A, Schloemer P, Eissing T, Dayoub R, Lawatscheck R, Agarwal R, FIND-CKD, FIDELIO-DKD and FIGARO-DKD Investigators

doi: 10.1016/S0140-6736(26)01009-3

Further Publications Urology

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Lancet

Heerspink HJL, Cardona JF, Jolly S, Pergola PE, de Sousa-Amorim E, Eriksson AL, Fredholm M, Gasparyan SB, Guzman NJ, Hartleib-Geschwindner J, Jiang Y, Leonsson-Zachrisson M, Mark PB, MIRO-CKD study investigators

doi: 10.1016/S0140-6736(25)02014-8

Further Publications Urology

Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications

Mayo Clin Proc

Cherney DZI, Alicic RZ, Bonaca MP

doi: 10.1016/j.mayocp.2026.01.010

Further Publications Urology

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

Adv Ther

Nangaku M, Sasaki K, Bi J, Ueta K, Nishimura K, Hashimoto T, Hata M

doi: 10.1007/s12325-025-03272-x

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and Dysfunctions

Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial

J Sex Med

Han TM, Helon J, Long B, Cheema A, Gonzalez N, Joyce C, Feffer M, McVary KT

doi: 10.1093/jsxmed/qdag135

Related content

System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland

Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus

Chronic kidney disease

Advances in understanding the impact of sex on kidney health and disease

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial